-
1
-
-
34848837386
-
Taking dendritic cells into medicine
-
Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature 2007;449(7161):419-426
-
(2007)
Nature
, vol.449
, Issue.7161
, pp. 419-426
-
-
Steinman, R.M.1
Banchereau, J.2
-
2
-
-
34248204110
-
DC-based cancer vaccines
-
Gilboa E. DC-based cancer vaccines. J Clin Invest 2007;117(5):1195-1203
-
(2007)
J Clin Invest
, vol.117
, Issue.5
, pp. 1195-1203
-
-
Gilboa, E.1
-
3
-
-
2442647551
-
Dendritic cell immunotherapy: Mapping the way
-
Figdor CG, De Vries IJ, Lesterhuis WJ, Melief CJ. Dendritic cell immunotherapy: mapping the way. Nat Med 2004;10(5):475-480
-
(2004)
Nat Med
, vol.10
, Issue.5
, pp. 475-480
-
-
Figdor, C.G.1
De Vries, I.J.2
Lesterhuis, W.J.3
Melief, C.J.4
-
4
-
-
0034121654
-
Dendritic cells in cancer immunotherapy
-
Fong L, Engleman EG. Dendritic cells in cancer immunotherapy. Annu Rev Immunol 2000;18:245-273
-
(2000)
Annu Rev Immunol
, vol.18
, pp. 245-273
-
-
Fong, L.1
Engleman, E.G.2
-
5
-
-
30144444279
-
Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells
-
Dannull J, Su Z, Rizzieri D, et al. Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. J Clin Invest 2005;115(12):3623-3633
-
(2005)
J Clin Invest
, vol.115
, Issue.12
, pp. 3623-3633
-
-
Dannull, J.1
Su, Z.2
Rizzieri, D.3
-
6
-
-
0036167308
-
Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors
-
Heiser A, Coleman D, Dannull J, et al. Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors. J Clin Invest 2002;109(3):409-417
-
(2002)
J Clin Invest
, vol.109
, Issue.3
, pp. 409-417
-
-
Heiser, A.1
Coleman, D.2
Dannull, J.3
-
7
-
-
0035284901
-
Induction of polyclonal prostate cancer-specific CTL using dendritic cells transfected with amplified tumor RNA
-
Heiser A, Maurice MA, Yancey DR, et al. Induction of polyclonal prostate cancer-specific CTL using dendritic cells transfected with amplified tumor RNA. J Immunol 2001;166(5):2953-2960
-
(2001)
J Immunol
, vol.166
, Issue.5
, pp. 2953-2960
-
-
Heiser, A.1
Maurice, M.A.2
Yancey, D.R.3
-
8
-
-
0041857805
-
Immunotherapy with autologous, human dendritic cells transfected with carcinoembryonic antigen mRNA
-
Morse MA, Nair SK, Mosca PJ, et al. Immunotherapy with autologous, human dendritic cells transfected with carcinoembryonic antigen mRNA. Cancer Invest 2003;21(3):341-349
-
(2003)
Cancer Invest
, vol.21
, Issue.3
, pp. 341-349
-
-
Morse, M.A.1
Nair, S.K.2
Mosca, P.J.3
-
9
-
-
0038066552
-
Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells
-
Su Z, Dannull J, Heiser A, et al. Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells. Cancer Res 2003;63(9):2127-2133
-
(2003)
Cancer Res
, vol.63
, Issue.9
, pp. 2127-2133
-
-
Su, Z.1
Dannull, J.2
Heiser, A.3
-
10
-
-
20144364773
-
Telomerase mRNA-transfected dendritic cells stimulate antigen-specific CD8+ and CD4+ T cell responses in patients with metastatic prostate cancer
-
Su Z, Dannull J, Yang BK, et al. Telomerase mRNA-transfected dendritic cells stimulate antigen-specific CD8+ and CD4+ T cell responses in patients with metastatic prostate cancer. J Immunol 2005;174(6):3798-3807
-
(2005)
J Immunol
, vol.174
, Issue.6
, pp. 3798-3807
-
-
Su, Z.1
Dannull, J.2
Yang, B.K.3
-
11
-
-
4644324025
-
Cancer immunotherapy: Moving beyond current vaccines
-
Rosenberg SA, Yang JC, Restifo NP. Cancer immunotherapy: moving beyond current vaccines. Nat Med 2004;10(9):909-915
-
(2004)
Nat Med
, vol.10
, Issue.9
, pp. 909-915
-
-
Rosenberg, S.A.1
Yang, J.C.2
Restifo, N.P.3
-
12
-
-
33746342994
-
Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease
-
Sakaguchi S, Ono M, Setoguchi R, et al. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006;212:8-27
-
(2006)
Immunol Rev
, vol.212
, pp. 8-27
-
-
Sakaguchi, S.1
Ono, M.2
Setoguchi, R.3
-
13
-
-
28544444136
-
The therapeutic implications of intratumoral regulatory T cells
-
Dranoff G. The therapeutic implications of intratumoral regulatory T cells. Clin Cancer Res 2005;11(23):8226-8229
-
(2005)
Clin Cancer Res
, vol.11
, Issue.23
, pp. 8226-8229
-
-
Dranoff, G.1
-
14
-
-
34248194231
-
Tregs and rethinking cancer immunotherapy
-
Curiel TJ. Tregs and rethinking cancer immunotherapy. J Clin Invest 2007;117(5):1167-1174
-
(2007)
J Clin Invest
, vol.117
, Issue.5
, pp. 1167-1174
-
-
Curiel, T.J.1
-
15
-
-
33645286546
-
Regulatory T cells, tumour immunity and immunotherapy
-
Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 2006;6(4):295-307
-
(2006)
Nat Rev Immunol
, vol.6
, Issue.4
, pp. 295-307
-
-
Zou, W.1
-
16
-
-
0029839058
-
Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo
-
Boczkowski D, Nair SK, Snyder D, Gilboa E. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J Exp Med 1996;184(2):465-472
-
(1996)
J Exp Med
, vol.184
, Issue.2
, pp. 465-472
-
-
Boczkowski, D.1
Nair, S.K.2
Snyder, D.3
Gilboa, E.4
-
17
-
-
0034652624
-
Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells
-
Boczkowski D, Nair SK, Nam JH, et al. Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells. Cancer Res 2000;60(4):1028-1034
-
(2000)
Cancer Res
, vol.60
, Issue.4
, pp. 1028-1034
-
-
Boczkowski, D.1
Nair, S.K.2
Nam, J.H.3
-
18
-
-
0033826798
-
Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells
-
Nair SK, Heiser A, Boczkowski D, et al. Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells. Nat Med 2000;6(9):1011-1017
-
(2000)
Nat Med
, vol.6
, Issue.9
, pp. 1011-1017
-
-
Nair, S.K.1
Heiser, A.2
Boczkowski, D.3
-
19
-
-
0033516548
-
Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA
-
Nair SK, Hull S, Coleman D, et al. Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA. Int J Cancer 1999;82(1):121-124
-
(1999)
Int J Cancer
, vol.82
, Issue.1
, pp. 121-124
-
-
Nair, S.K.1
Hull, S.2
Coleman, D.3
-
20
-
-
2942559009
-
Cancer immunotherapy with mRNA-transfected dendritic cells
-
Gilboa E, Vieweg J. Cancer immunotherapy with mRNA-transfected dendritic cells. Immunol Rev 2004;199:251-263
-
(2004)
Immunol Rev
, vol.199
, pp. 251-263
-
-
Gilboa, E.1
Vieweg, J.2
-
21
-
-
0038667887
-
RNA-transfected dendritic cells
-
Nair S, Boczkowski D. RNA-transfected dendritic cells. Expert Rev Vaccines 2002;1(4):507-513
-
(2002)
Expert Rev Vaccines
, vol.1
, Issue.4
, pp. 507-513
-
-
Nair, S.1
Boczkowski, D.2
-
24
-
-
70449637946
-
Dendritic cells engineered to secrete anti-GITR antibodies are effective adjuvants to dendritic cell-based immunotherapy
-
Boczkowski D, Lee J, Pruitt S, Nair S. Dendritic cells engineered to secrete anti-GITR antibodies are effective adjuvants to dendritic cell-based immunotherapy. Cancer Gene Ther 2009;16(12):900-911
-
(2009)
Cancer Gene Ther
, vol.16
, Issue.12
, pp. 900-911
-
-
Boczkowski, D.1
Lee, J.2
Pruitt, S.3
Nair, S.4
-
25
-
-
0023504679
-
MRNA caps-old and newer hats
-
Shatkin AJ. mRNA caps-old and newer hats. Bioessays 1987;7(6):275-277
-
(1987)
Bioessays
, vol.7
, Issue.6
, pp. 275-277
-
-
Shatkin, A.J.1
-
26
-
-
0034768443
-
Synthesis and properties of mRNAs containing the novel "anti-reverse" cap analogs 7-methyl(3′-O-methyl)GpppG and 7-methyl (3′-deoxy)GpppG
-
Stepinski J, Waddell C, Stolarski R, et al. Synthesis and properties of mRNAs containing the novel "anti-reverse" cap analogs 7-methyl(3′-O-methyl)GpppG and 7-methyl (3′-deoxy)GpppG. RNA 2001;7(10):1486-1495
-
(2001)
RNA
, vol.7
, Issue.10
, pp. 1486-1495
-
-
Stepinski, J.1
Waddell, C.2
Stolarski, R.3
-
27
-
-
55249105461
-
Ectopic expression of a truncated CD40L protein from synthetic post-transcriptionally capped RNA in dendritic cells induces high levels of IL-12 secretion
-
Published online 17 October 2008, doi:10.1186/1471-2199-9-90
-
Tcherepanova IY, Adams MD, Feng X, et al. Ectopic expression of a truncated CD40L protein from synthetic post-transcriptionally capped RNA in dendritic cells induces high levels of IL-12 secretion. BMC Mol Biol 2008;9:90. Published online 17 October 2008, doi:10.1186/1471-2199-9-90
-
(2008)
BMC Mol Biol
, vol.9
, pp. 90
-
-
Tcherepanova, I.Y.1
Adams, M.D.2
Feng, X.3
-
28
-
-
39649100209
-
Enhanced protein expression by internal ribosomal entry site-driven mRNA translation as a novel approach for in vitro loading of dendritic cells with antigens
-
Tan X, Wan Y. Enhanced protein expression by internal ribosomal entry site-driven mRNA translation as a novel approach for in vitro loading of dendritic cells with antigens. Hum Immunol 2008;69(1):32-40
-
(2008)
Hum Immunol
, vol.69
, Issue.1
, pp. 32-40
-
-
Tan, X.1
Wan, Y.2
-
29
-
-
0036207282
-
Untranslated regions of mRNAs
-
Published online 28 February 2002, doi:10.1186/gb-2002-3-3-reviews0004
-
Mignone F, Gissi C, Liuni S, Pesole G. Untranslated regions of mRNAs. Genome Biol 2002;3(3):REVIEWS0004. Published online 28 February 2002, doi:10.1186/gb-2002-3-3-reviews0004
-
(2002)
Genome Biol
, vol.3
, Issue.3
-
-
Mignone, F.1
Gissi, C.2
Liuni, S.3
Pesole, G.4
-
30
-
-
0034898553
-
Structural and functional analysis of an mRNP complex that mediates the high stability of human beta-globin mRNA
-
Yu J, Russell JE. Structural and functional analysis of an mRNP complex that mediates the high stability of human beta-globin mRNA. Mol Cell Biol 2001;21(17):5879-5888
-
(2001)
Mol Cell Biol
, vol.21
, Issue.17
, pp. 5879-5888
-
-
Yu, J.1
Russell, J.E.2
-
31
-
-
30544433619
-
MRNA transfection of dendritic cells: Synergistic effect of ARCA mRNA capping with poly(A) chains in cis and in trans for a high protein expression level
-
Mockey M, Goncalves C, Dupuy FP, et al. mRNA transfection of dendritic cells: synergistic effect of ARCA mRNA capping with poly(A) chains in cis and in trans for a high protein expression level. Biochem Biophys Res Commun 2006;340(4):1062-1068
-
(2006)
Biochem Biophys Res Commun
, vol.340
, Issue.4
, pp. 1062-1068
-
-
Mockey, M.1
Goncalves, C.2
Dupuy, F.P.3
-
32
-
-
0037184089
-
Free poly(A) stimulates capped mRNA translation in vitro through the eIF4G-poly(A)-binding protein interaction
-
Borman AM, Michel YM, Malnou CE, Kean KM. Free poly(A) stimulates capped mRNA translation in vitro through the eIF4G-poly(A)-binding protein interaction. J Biol Chem 2002;277(39):36818-36824
-
(2002)
J Biol Chem
, vol.277
, Issue.39
, pp. 36818-36824
-
-
Borman, A.M.1
Michel, Y.M.2
Malnou, C.E.3
Kean, K.M.4
-
33
-
-
33845497677
-
Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells
-
Holtkamp S, Kreiter S, Selmi A, et al. Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells. Blood 2006;108(13):4009-4017
-
(2006)
Blood
, vol.108
, Issue.13
, pp. 4009-4017
-
-
Holtkamp, S.1
Kreiter, S.2
Selmi, A.3
-
34
-
-
0344837817
-
The feasibility and safety of immunotherapy with dendritic cells loaded with CEA mRNA following neoadjuvant chemoradiotherapy and resection of pancreatic cancer
-
Morse MA, Nair SK, Boczkowski D, et al. The feasibility and safety of immunotherapy with dendritic cells loaded with CEA mRNA following neoadjuvant chemoradiotherapy and resection of pancreatic cancer. Int J Gastrointest Cancer 2002;32(1):1-6
-
(2002)
Int J Gastrointest Cancer
, vol.32
, Issue.1
, pp. 1-6
-
-
Morse, M.A.1
Nair, S.K.2
Boczkowski, D.3
-
35
-
-
0035412401
-
Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: Superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells
-
Van Tendeloo VF, Ponsaerts P, Lardon F, et al. Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells. Blood 2001;98(1):49-56
-
(2001)
Blood
, vol.98
, Issue.1
, pp. 49-56
-
-
Van Tendeloo, V.F.1
Ponsaerts, P.2
Lardon, F.3
-
36
-
-
4644275422
-
Side-by-side comparison of lentivirally transduced and mRNA-electroporated dendritic cells: Implications for cancer immunotherapy protocols
-
Dullaers M, Breckpot K, Van Meirvenne S, et al. Side-by-side comparison of lentivirally transduced and mRNA-electroporated dendritic cells: implications for cancer immunotherapy protocols. Mol Ther 2004;10(4):768-779
-
(2004)
Mol Ther
, vol.10
, Issue.4
, pp. 768-779
-
-
Dullaers, M.1
Breckpot, K.2
Van Meirvenne, S.3
-
37
-
-
34548067624
-
Interleukin-12: Biological properties and clinical application
-
Del Vecchio M, Bajetta E, Canova S, et al. Interleukin-12: biological properties and clinical application. Clin Cancer Res 2007;13(16):4677-4685
-
(2007)
Clin Cancer Res
, vol.13
, Issue.16
, pp. 4677-4685
-
-
Del Vecchio, M.1
Bajetta, E.2
Canova, S.3
-
38
-
-
51649115332
-
High-level antigen expression and sustained antigen presentation in dendritic cells nucleofected with wild-type viral mRNA but not DNA
-
Melhem NM, Gleason SM, Liu XD, Barratt-Boyes SM. High-level antigen expression and sustained antigen presentation in dendritic cells nucleofected with wild-type viral mRNA but not DNA. Clin Vaccine Immunol 2008;15(9):1337-1344
-
(2008)
Clin Vaccine Immunol
, vol.15
, Issue.9
, pp. 1337-1344
-
-
Melhem, N.M.1
Gleason, S.M.2
Liu, X.D.3
Barratt-Boyes, S.M.4
-
39
-
-
34848813477
-
High transfection efficiency, gene expression, and viability of monocyte-derived human dendritic cells after nonviral gene transfer
-
Landi A, Babiuk LA, Van Drunen Littel-Van Den Hurk S. High transfection efficiency, gene expression, and viability of monocyte-derived human dendritic cells after nonviral gene transfer. J Leukoc Biol 2007;82(4):849-860
-
(2007)
J Leukoc Biol
, vol.82
, Issue.4
, pp. 849-860
-
-
Landi, A.1
Babiuk, L.A.2
Van Drunen Littel-Van Den Hurk, S.3
-
40
-
-
0141564862
-
Induction of influenza matrix protein 1 and MelanA-specific T lymphocytes in vitro using mRNA-electroporated dendritic cells
-
Tuyaerts S, Michiels A, Corthals J, et al. Induction of influenza matrix protein 1 and MelanA-specific T lymphocytes in vitro using mRNA-electroporated dendritic cells. Cancer Gene Ther 2003;10(9):696-706
-
(2003)
Cancer Gene Ther
, vol.10
, Issue.9
, pp. 696-706
-
-
Tuyaerts, S.1
Michiels, A.2
Corthals, J.3
-
41
-
-
56449097201
-
Type 2 bias of T cells expanded from the blood of melanoma patients switched to type 1 by IL-12p70 mRNA-transfected dendritic cells
-
Minkis K, Kavanagh DG, Alter G, et al. Type 2 bias of T cells expanded from the blood of melanoma patients switched to type 1 by IL-12p70 mRNA-transfected dendritic cells. Cancer Res 2008;68(22):9441-9450
-
(2008)
Cancer Res
, vol.68
, Issue.22
, pp. 9441-9450
-
-
Minkis, K.1
Kavanagh, D.G.2
Alter, G.3
-
42
-
-
33846912739
-
Dendritic cells transfected with interleukin-12 and tumor-associated antigen messenger RNA induce high avidity cytotoxic T cells
-
Bontkes HJ, Kramer D, Ruizendaal JJ, et al. Dendritic cells transfected with interleukin-12 and tumor-associated antigen messenger RNA induce high avidity cytotoxic T cells. Gene Ther 2007;14(4):366-375
-
(2007)
Gene Ther
, vol.14
, Issue.4
, pp. 366-375
-
-
Bontkes, H.J.1
Kramer, D.2
Ruizendaal, J.J.3
-
43
-
-
47249089097
-
IL-1, IL-18, and IL-33 families of cytokines
-
Arend WP, Palmer G, Gabay C. IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev 2008;223:20-38
-
(2008)
Immunol Rev
, vol.223
, pp. 20-38
-
-
Arend, W.P.1
Palmer, G.2
Gabay, C.3
-
44
-
-
45249113920
-
Tumor associated antigen and interleukin-12 mRNA transfected dendritic cells enhance effector function of natural killer cells and antigen specific T-cells
-
Bontkes HJ, Kramer D, Ruizendaal JJ, et al. Tumor associated antigen and interleukin-12 mRNA transfected dendritic cells enhance effector function of natural killer cells and antigen specific T-cells. Clin Immunol 2008;127(3):375-384
-
(2008)
Clin Immunol
, vol.127
, Issue.3
, pp. 375-384
-
-
Bontkes, H.J.1
Kramer, D.2
Ruizendaal, J.J.3
-
45
-
-
2442707774
-
Induction of human dendritic cell maturation using transfection with RNA encoding a dominant positive toll-like receptor 4
-
Cisco RM, Abdel-Wahab Z, Dannull J, et al. Induction of human dendritic cell maturation using transfection with RNA encoding a dominant positive toll-like receptor 4. J Immunol 2004;172(11):7162-7168
-
(2004)
J Immunol
, vol.172
, Issue.11
, pp. 7162-7168
-
-
Cisco, R.M.1
Abdel-Wahab, Z.2
Dannull, J.3
-
46
-
-
16244381163
-
Cotransfection of DC with TLR4 and MART-1 RNA induces MART-1-specific responses
-
Abdel-Wahab Z, Cisco R, Dannull J, et al. Cotransfection of DC with TLR4 and MART-1 RNA induces MART-1-specific responses. J Surg Res 2005;124(2):264-273
-
(2005)
J Surg Res
, vol.124
, Issue.2
, pp. 264-273
-
-
Abdel-Wahab, Z.1
Cisco, R.2
Dannull, J.3
-
47
-
-
44349173032
-
Enhancing the T-cell stimulatory capacity of human dendritic cells by co-electroporation with CD40L, CD70 and constitutively active TLR4 encoding mRNA
-
Bonehill A, Tuyaerts S, Van Nuffel AM, et al. Enhancing the T-cell stimulatory capacity of human dendritic cells by co-electroporation with CD40L, CD70 and constitutively active TLR4 encoding mRNA. Mol Ther 2008;16(6):1170-1180
-
(2008)
Mol Ther
, vol.16
, Issue.6
, pp. 1170-1180
-
-
Bonehill, A.1
Tuyaerts, S.2
Van Nuffel, A.M.3
-
48
-
-
66149186858
-
Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients
-
Bonehill A, Van Nuffel AM, Corthals J, et al. Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients. Clin Cancer Res 2009;15(10):3366-3375
-
(2009)
Clin Cancer Res
, vol.15
, Issue.10
, pp. 3366-3375
-
-
Bonehill, A.1
Van Nuffel, A.M.2
Corthals, J.3
-
49
-
-
65349144269
-
Timing and tuning of CD27-CD70 interactions: The impact of signal strength in setting the balance between adaptive responses and immunopathology
-
Nolte MA, Van Olffen RW, Van Gisbergen KP, Van Lier RA. Timing and tuning of CD27-CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology. Immunol Rev 2009;229(1):216-231
-
(2009)
Immunol Rev
, vol.229
, Issue.1
, pp. 216-231
-
-
Nolte, M.A.1
Van Olffen, R.W.2
Van Gisbergen, K.P.3
Van Lier, R.A.4
-
50
-
-
0034329745
-
CD27 is required for generation and long-term maintenance of T cell immunity
-
Hendriks J, Gravestein LA, Tesselaar K, et al. CD27 is required for generation and long-term maintenance of T cell immunity. Nat Immunol 2000;1(5):433-440
-
(2000)
Nat Immunol
, vol.1
, Issue.5
, pp. 433-440
-
-
Hendriks, J.1
Gravestein, L.A.2
Tesselaar, K.3
-
51
-
-
17044427679
-
Enhancing the immunostimulatory function of dendritic cells by transfection with mRNA encoding OX40 ligand
-
Dannull J, Nair S, Su Z, et al. Enhancing the immunostimulatory function of dendritic cells by transfection with mRNA encoding OX40 ligand. Blood 2005;105(8):3206-3213
-
(2005)
Blood
, vol.105
, Issue.8
, pp. 3206-3213
-
-
Dannull, J.1
Nair, S.2
Su, Z.3
-
52
-
-
23944454886
-
Cotransfection of dendritic cells with RNA coding for HER-2/neu and 4-1BBL increases the induction of tumor antigen specific cytotoxic T lymphocytes
-
Grunebach F, Kayser K, Weck MM, et al. Cotransfection of dendritic cells with RNA coding for HER-2/neu and 4-1BBL increases the induction of tumor antigen specific cytotoxic T lymphocytes. Cancer Gene Ther 2005;12(9):749-756
-
(2005)
Cancer Gene Ther
, vol.12
, Issue.9
, pp. 749-756
-
-
Grunebach, F.1
Kayser, K.2
Weck, M.M.3
-
53
-
-
3242680883
-
Small interference RNA modulation of IL-10 in human monocyte-derived dendritic cells enhances the Th1 response
-
Liu G, Ng H, Akasaki Y, et al. Small interference RNA modulation of IL-10 in human monocyte-derived dendritic cells enhances the Th1 response. Eur J Immunol 2004;34(6):1680-1687
-
(2004)
Eur J Immunol
, vol.34
, Issue.6
, pp. 1680-1687
-
-
Liu, G.1
Ng, H.2
Akasaki, Y.3
-
54
-
-
60549088603
-
Attenuated expression of A20 markedly increases the efficacy of double-stranded RNA-activated dendritic cells as an anti-cancer vaccine
-
Breckpot K, Aerts-Toegaert C, Heirman C, et al. Attenuated expression of A20 markedly increases the efficacy of double-stranded RNA-activated dendritic cells as an anti-cancer vaccine. J Immunol 2009;182(2):860-870
-
(2009)
J Immunol
, vol.182
, Issue.2
, pp. 860-870
-
-
Breckpot, K.1
Aerts-Toegaert, C.2
Heirman, C.3
-
55
-
-
19644396618
-
Vaccination with dendritic cells transfected with BAK and BAX siRNA enhances antigen-specific immune responses by prolonging dendritic cell life
-
Peng S, Kim TW, Lee JH, et al. Vaccination with dendritic cells transfected with BAK and BAX siRNA enhances antigen-specific immune responses by prolonging dendritic cell life. Hum Gene Ther 2005;16(5):584-593
-
(2005)
Hum Gene Ther
, vol.16
, Issue.5
, pp. 584-593
-
-
Peng, S.1
Kim, T.W.2
Lee, J.H.3
-
56
-
-
33947148205
-
Enhancing dendritic cell vaccine potency by combining a BAK/BAX siRNA-mediated antiapoptotic strategy to prolong dendritic cell life with an intracellular strategy to target antigen to lysosomal compartments
-
Kang TH, Lee JH, Noh KH, et al. Enhancing dendritic cell vaccine potency by combining a BAK/BAX siRNA-mediated antiapoptotic strategy to prolong dendritic cell life with an intracellular strategy to target antigen to lysosomal compartments. Int J Cancer 2007;120(8):1696-1703
-
(2007)
Int J Cancer
, vol.120
, Issue.8
, pp. 1696-1703
-
-
Kang, T.H.1
Lee, J.H.2
Noh, K.H.3
-
57
-
-
39649085607
-
Immunoproteasome down-modulation enhances the ability of dendritic cells to stimulate antitumor immunity
-
Dannull J, Lesher DT, Holzknecht R, et al. Immunoproteasome down-modulation enhances the ability of dendritic cells to stimulate antitumor immunity. Blood 2007;110(13):4341-4350
-
(2007)
Blood
, vol.110
, Issue.13
, pp. 4341-4350
-
-
Dannull, J.1
Lesher, D.T.2
Holzknecht, R.3
-
58
-
-
66249105368
-
Maclachlan I. siRNA and innate immunity
-
Robbins M, Judge A, Maclachlan I. siRNA and innate immunity. Oligonucleotides 2009;19(2):89-102
-
(2009)
Oligonucleotides
, vol.19
, Issue.2
, pp. 89-102
-
-
Robbins, M.1
Judge, A.2
-
60
-
-
1542317550
-
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
-
Diebold SS, Kaisho T, Hemmi H, et al. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004;303(5663):1529-1531
-
(2004)
Science
, vol.303
, Issue.5663
, pp. 1529-1531
-
-
Diebold, S.S.1
Kaisho, T.2
Hemmi, H.3
-
61
-
-
1542317578
-
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
-
Heil F, Hemmi H, Hochrein H, et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004;303(5663):1526- 1529
-
(2004)
Science
, vol.303
, Issue.5663
, pp. 1526-1529
-
-
Heil, F.1
Hemmi, H.2
Hochrein, H.3
-
62
-
-
20144389695
-
Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7
-
Hornung V, Guenthner-Biller M, Bourquin C, et al. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med 2005;11(3):263-270
-
(2005)
Nat Med
, vol.11
, Issue.3
, pp. 263-270
-
-
Hornung, V.1
Guenthner-Biller, M.2
Bourquin, C.3
-
63
-
-
0037080024
-
Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines
-
Zarember KA, Godowski PJ. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 2002;168(2):554-561
-
(2002)
J Immunol
, vol.168
, Issue.2
, pp. 554-561
-
-
Zarember, K.A.1
Godowski, P.J.2
-
64
-
-
33947607799
-
Immunostimulatory RNA oligonucleotides trigger an antigen-specific cytotoxic T-cell and IgG2a response
-
Bourquin C, Schmidt L, Hornung V, et al. Immunostimulatory RNA oligonucleotides trigger an antigen-specific cytotoxic T-cell and IgG2a response. Blood 2007;109(7):2953-2960
-
(2007)
Blood
, vol.109
, Issue.7
, pp. 2953-2960
-
-
Bourquin, C.1
Schmidt, L.2
Hornung, V.3
-
65
-
-
22344454846
-
Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA
-
Judge AD, Sood V, Shaw JR, et al. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat Biotechnol 2005;23(4):457-462
-
(2005)
Nat Biotechnol
, vol.23
, Issue.4
, pp. 457-462
-
-
Judge, A.D.1
Sood, V.2
Shaw, J.R.3
-
66
-
-
18044365415
-
Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization
-
Sioud M. Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization. J Mol Biol 2005;348(5):1079-1090
-
(2005)
J Mol Biol
, vol.348
, Issue.5
, pp. 1079-1090
-
-
Sioud, M.1
-
67
-
-
0035909372
-
Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3
-
Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001;413(6857):732-738
-
(2001)
Nature
, vol.413
, Issue.6857
, pp. 732-738
-
-
Alexopoulou, L.1
Holt, A.C.2
Medzhitov, R.3
Flavell, R.A.4
-
68
-
-
33750976374
-
5prime;-Triphosphate RNA is the ligand for RIG-I
-
Hornung V, Ellegast J, Kim S, et al. 5prime;-Triphosphate RNA is the ligand for RIG-I. Science 2006;314(5801):994-997
-
(2006)
Science
, vol.314
, Issue.5801
, pp. 994-997
-
-
Hornung, V.1
Ellegast, J.2
Kim, S.3
-
69
-
-
33646342149
-
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
-
Kato H, Takeuchi O, Sato S, et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006;441(7089):101-105
-
(2006)
Nature
, vol.441
, Issue.7089
, pp. 101-105
-
-
Kato, H.1
Takeuchi, O.2
Sato, S.3
-
70
-
-
0026929934
-
Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth
-
Meurs EF, Watanabe Y, Kadereit S, et al. Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth. J Virol 1992;66(10):5805-5814
-
(1992)
J Virol
, vol.66
, Issue.10
, pp. 5805-5814
-
-
Meurs, E.F.1
Watanabe, Y.2
Kadereit, S.3
-
71
-
-
3242813113
-
The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses
-
Yoneyama M, Kikuchi M, Natsukawa T, et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004;5(7):730-737
-
(2004)
Nat Immunol
, vol.5
, Issue.7
, pp. 730-737
-
-
Yoneyama, M.1
Kikuchi, M.2
Natsukawa, T.3
-
72
-
-
65249088470
-
Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients
-
Verdijk P, Aarntzen EH, Lesterhuis WJ, et al. Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients. Clin Cancer Res 2009;15(7):2531-2540
-
(2009)
Clin Cancer Res
, vol.15
, Issue.7
, pp. 2531-2540
-
-
Verdijk, P.1
Aarntzen, E.H.2
Lesterhuis, W.J.3
-
73
-
-
0042526005
-
Gene therapy to target dendritic cells from blood to lymph nodes
-
Robert C, Klein C, Cheng G, et al. Gene therapy to target dendritic cells from blood to lymph nodes. Gene Ther 2003;10(17):1479-1486
-
(2003)
Gene Ther
, vol.10
, Issue.17
, pp. 1479-1486
-
-
Robert, C.1
Klein, C.2
Cheng, G.3
-
74
-
-
38649110793
-
Introduction of functional chimeric E/ L-selectin by RNA electroporation to target dendritic cells from blood to lymph nodes
-
Dorrie J, Schaft N, Muller I, et al. Introduction of functional chimeric E/ L-selectin by RNA electroporation to target dendritic cells from blood to lymph nodes. Cancer Immunol Immunother 2008;57(4):467-477
-
(2008)
Cancer Immunol Immunother
, vol.57
, Issue.4
, pp. 467-477
-
-
Dorrie, J.1
Schaft, N.2
Muller, I.3
-
76
-
-
33846465547
-
Immunostimulatory monoclonal antibodies for cancer therapy
-
Melero I, Hervas-Stubbs S, Glennie M, et al. Immunostimulatory monoclonal antibodies for cancer therapy. Nat Rev Cancer 2007;7(2):95-106
-
(2007)
Nat Rev Cancer
, vol.7
, Issue.2
, pp. 95-106
-
-
Melero, I.1
Hervas-Stubbs, S.2
Glennie, M.3
-
77
-
-
66849135251
-
Cancer immunotherapy: Co-stimulatory agonists and co-inhibitory antagonists
-
Peggs KS, Quezada SA, Allison JP. Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists. Clin Exp Immunol 2009;157(1):9-19
-
(2009)
Clin Exp Immunol
, vol.157
, Issue.1
, pp. 9-19
-
-
Peggs, K.S.1
Quezada, S.A.2
Allison, J.P.3
-
78
-
-
65349119978
-
CD28 and CTLA-4 coreceptor expression and signal transduction
-
Rudd CE, Taylor A, Schneider H. CD28 and CTLA-4 coreceptor expression and signal transduction. Immunol Rev 2009;229(1):12-26
-
(2009)
Immunol Rev
, vol.229
, Issue.1
, pp. 12-26
-
-
Rudd, C.E.1
Taylor, A.2
Schneider, H.3
-
79
-
-
0029947568
-
Enhancement of antitumor immunity by CTLA-4 blockade
-
Leach DR, Krummel MF, Allison JP. Enhancement of antitumor immunity by CTLA-4 blockade. Science 1996;271(5256):1734-1736
-
(1996)
Science
, vol.271
, Issue.5256
, pp. 1734-1736
-
-
Leach, D.R.1
Krummel, M.F.2
Allison, J.P.3
-
80
-
-
33745851479
-
CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells
-
Quezada SA, Peggs KS, Curran MA, Allison JP. CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells. J Clin Invest 2006;116(7):1935-1945
-
(2006)
J Clin Invest
, vol.116
, Issue.7
, pp. 1935-1945
-
-
Quezada, S.A.1
Peggs, K.S.2
Curran, M.A.3
Allison, J.P.4
-
81
-
-
0033517152
-
Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation
-
Van Elsas A, Hurwitz AA, Allison JP. Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation. J Exp Med 1999;190(3):355-366
-
(1999)
J Exp Med
, vol.190
, Issue.3
, pp. 355-366
-
-
Van Elsas, A.1
Hurwitz, A.A.2
Allison, J.P.3
-
82
-
-
11144353596
-
CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems
-
Gregor PD, Wolchok JD, Ferrone CR, et al. CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems. Vaccine 2004;22(13-14):1700-1708
-
(2004)
Vaccine
, vol.22
, Issue.13-14
, pp. 1700-1708
-
-
Gregor, P.D.1
Wolchok, J.D.2
Ferrone, C.R.3
-
83
-
-
36248987929
-
The role of the CTLA4 blockade in the treatment of malignant melanoma
-
Cranmer LD, Hersh E. The role of the CTLA4 blockade in the treatment of malignant melanoma. Cancer Invest 2007;25(7):613-631
-
(2007)
Cancer Invest
, vol.25
, Issue.7
, pp. 613-631
-
-
Cranmer, L.D.1
Hersh, E.2
-
84
-
-
0344341626
-
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
-
Hodi FS, Mihm MC, Soiffer RJ, et al. Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proc Natl Acad Sci USA 2003;100(8):4712-4717
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, Issue.8
, pp. 4712-4717
-
-
Hodi, F.S.1
Mihm, M.C.2
Soiffer, R.J.3
-
85
-
-
0038153907
-
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
-
Phan GQ, Yang JC, Sherry RM, et al. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc Natl Acad Sci USA 2003;100(14):8372-8377
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, Issue.14
, pp. 8372-8377
-
-
Phan, G.Q.1
Yang, J.C.2
Sherry, R.M.3
-
86
-
-
34250223096
-
A pilot trial of CTLA-4 blockade with human anti-CTLA-4 in patients with hormone-refractory prostate cancer
-
Small EJ, Tchekmedyian NS, Rini BI, et al. A pilot trial of CTLA-4 blockade with human anti-CTLA-4 in patients with hormone-refractory prostate cancer. Clin Cancer Res 2007;13(6):1810-1815
-
(2007)
Clin Cancer Res
, vol.13
, Issue.6
, pp. 1810-1815
-
-
Small, E.J.1
Tchekmedyian, N.S.2
Rini, B.I.3
-
87
-
-
27444440093
-
Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer
-
Blansfield JA, Beck KE, Tran K, et al. Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer. J Immunother 2005;28(6):593-598
-
(2005)
J Immunother
, vol.28
, Issue.6
, pp. 593-598
-
-
Blansfield, J.A.1
Beck, K.E.2
Tran, K.3
-
88
-
-
44249090471
-
Local secretion of anti-CTLA-4 enhances the therapeutic efficacy of a cancer immunotherapy with reduced evidence of systemic autoimmunity
-
Simmons AD, Moskalenko M, Creson J, et al. Local secretion of anti-CTLA-4 enhances the therapeutic efficacy of a cancer immunotherapy with reduced evidence of systemic autoimmunity. Cancer Immunol Immunother 2008 57(8):1263-1270
-
(2008)
Cancer Immunol Immunother
, vol.57
, Issue.8
, pp. 1263-1270
-
-
Simmons, A.D.1
Moskalenko, M.2
Creson, J.3
-
89
-
-
17444414236
-
GITR: A multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily
-
Nocentini G, Riccardi C. GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily. Eur J Immunol 2005;35(4):1016-1022
-
(2005)
Eur J Immunol
, vol.35
, Issue.4
, pp. 1016-1022
-
-
Nocentini, G.1
Riccardi, C.2
-
90
-
-
33746575650
-
The GITR- GITRL interaction: Co-stimulation or contrasuppression of regulatory activity?
-
Shevach EM, Stephens GL: The GITR- GITRL interaction: co-stimulation or contrasuppression of regulatory activity? Nat Rev Immunol 2006;6(8):613-618
-
(2006)
Nat Rev Immunol
, vol.6
, Issue.8
, pp. 613-618
-
-
Shevach, E.M.1
Stephens, G.L.2
-
91
-
-
25844517914
-
Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells
-
Ko K, Yamazaki S, Nakamura K, et al. Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells. J Exp Med 2005;202(7):885-891
-
(2005)
J Exp Med
, vol.202
, Issue.7
, pp. 885-891
-
-
Ko, K.1
Yamazaki, S.2
Nakamura, K.3
-
92
-
-
33646876477
-
Glucocorticoid-induced TNF receptor family related gene activation overcomes tolerance/ignorance to melanoma differentiation antigens and enhances antitumor immunity
-
Ramirez-Montagut T, Chow A, Hirschhorn-Cymerman D, et al. Glucocorticoid-induced TNF receptor family related gene activation overcomes tolerance/ignorance to melanoma differentiation antigens and enhances antitumor immunity. J Immunol 2006;176(11):6434-6442
-
(2006)
J Immunol
, vol.176
, Issue.11
, pp. 6434-6442
-
-
Ramirez-Montagut, T.1
Chow, A.2
Hirschhorn-Cymerman, D.3
-
93
-
-
0036170938
-
Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance
-
Shimizu J, Yamazaki S, Takahashi T, et al. Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 2002;3(2):135-142
-
(2002)
Nat Immunol
, vol.3
, Issue.2
, pp. 135-142
-
-
Shimizu, J.1
Yamazaki, S.2
Takahashi, T.3
-
94
-
-
38849154553
-
Pivotal roles of CD4+ effector T cells in mediating agonistic anti-GITR mAb-induced-immune activation and tumor immunity in CT26 tumors
-
Zhou P, L'italien L, Hodges D, Schebye XM. Pivotal roles of CD4+ effector T cells in mediating agonistic anti-GITR mAb-induced-immune activation and tumor immunity in CT26 tumors. J Immunol 2007;179(11):7365-7375
-
(2007)
J Immunol
, vol.179
, Issue.11
, pp. 7365-7375
-
-
Zhou, P.1
L'Italien, L.2
Hodges, D.3
Schebye, X.M.4
-
95
-
-
33646419260
-
Agonist anti-GITR antibody enhances vaccine-induced CD8+ T-cell responses and tumor immunity
-
Cohen AD, Diab A, Perales MA, et al. Agonist anti-GITR antibody enhances vaccine-induced CD8+ T-cell responses and tumor immunity. Cancer Res 2006;66(9):4904-4912
-
(2006)
Cancer Res
, vol.66
, Issue.9
, pp. 4904-4912
-
-
Cohen, A.D.1
Diab, A.2
Perales, M.A.3
-
96
-
-
22244440787
-
In vivo ligation of glucocorticoid-induced TNF receptor enhances the T-cell immunity to herpes simplex virus type 1
-
La S, Kim E, Kwon B. In vivo ligation of glucocorticoid-induced TNF receptor enhances the T-cell immunity to herpes simplex virus type 1. Exp Mol Med 2005;37(3):193-198
-
(2005)
Exp Mol Med
, vol.37
, Issue.3
, pp. 193-198
-
-
La, S.1
Kim, E.2
Kwon, B.3
-
97
-
-
48649083285
-
Regulatory T cell-resistant CD8+ T cells induced by glucocorticoid- induced tumor necrosis factor receptor signaling
-
Nishikawa H, Kato T, Hirayama M, et al. Regulatory T cell-resistant CD8+ T cells induced by glucocorticoid-induced tumor necrosis factor receptor signaling. Cancer Res 2008;68(14):5948-5954
-
(2008)
Cancer Res
, vol.68
, Issue.14
, pp. 5948-5954
-
-
Nishikawa, H.1
Kato, T.2
Hirayama, M.3
-
98
-
-
0030962132
-
A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis
-
Nocentini G, Giunchi L, Ronchetti S, et al. A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis. Proc Natl Acad Sci USA 1997;94(12):6216-6221
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, Issue.12
, pp. 6216-6221
-
-
Nocentini, G.1
Giunchi, L.2
Ronchetti, S.3
-
99
-
-
6344279933
-
Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells
-
Stephens GL, Mchugh RS, Whitters MJ, et al. Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. J Immunol 2004;173(8):5008-5020
-
(2004)
J Immunol
, vol.173
, Issue.8
, pp. 5008-5020
-
-
Stephens, G.L.1
McHugh, R.S.2
Whitters, M.J.3
-
100
-
-
2942532501
-
Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25+ regulatory CD4+ T cells
-
Kanamaru F, Youngnak P, Hashiguchi M, et al. Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25+ regulatory CD4+ T cells. J Immunol 2004;172(12):7306-7314
-
(2004)
J Immunol
, vol.172
, Issue.12
, pp. 7306-7314
-
-
Kanamaru, F.1
Youngnak, P.2
Hashiguchi, M.3
-
101
-
-
17644386490
-
Development of humanized antibodies as cancer therapeutics
-
Qu Z, Griffiths GL, Wegener WA, et al. Development of humanized antibodies as cancer therapeutics. Methods 2005;36(1):84-95
-
(2005)
Methods
, vol.36
, Issue.1
, pp. 84-95
-
-
Qu, Z.1
Griffiths, G.L.2
Wegener, W.A.3
|